NASDAQ : SHPH
Shuttle Pharmaceuticals Holdings, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 5.23 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 24.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 9.44M | 7.86M | 4.08M | 2.38M | 1.41M | 721.18K |
| Research & Development | 1.78M | 4.05M | 3.62M | 3.52M | 1.15M | 1.02M |
| Operating Expenses | 11.22M | 11.92M | 7.70M | 5.89M | 2.55M | 1.74M |
| Operating Income | -11.22M | -11.92M | -7.70M | -5.89M | -2.55M | -1.74M |
| Interest Expense | -49.28K | -70.83K | -1.21M | -2.49M | -969.89K | -50.79K |
| Interest & Investment Income | 1.31K | 1.09K | 38.14K | 79.12K | ||
| Other Non Operating Income (Expenses) | -88.47K | -77.76K | 525.62K | 2.11M | 94.03K | 579.15K |
| EBT Excluding Unusual Items | -11.36M | -12.06M | -8.34M | -6.19M | -3.43M | -1.21M |
| Gain (Loss) on Sale of Investments | 28.55K | 76.54K | ||||
| Other Unusual Items | 1.10M | 342.65K | -833.50K | -477.22K | 401.69K | 62.50K |
| Pretax Income | -10.26M | -11.72M | -9.14M | -6.59M | -3.03M | -1.15M |
| Net Income | -10.26M | -11.72M | -9.14M | -6.59M | -3.03M | -1.15M |
| Preferred Dividends & Other Adjustments | 71.01K | 103.06K | ||||
| Net Income to Common | -10.26M | -11.72M | -9.14M | -6.59M | -3.10M | -1.26M |
| Shares Outstanding (Basic) | 505.78K | 163.79K | 11.48K | |||
| Shares Outstanding (Diluted) | 505.78K | 163.79K | 11.55K | |||
| EPS (Basic) | -20.29 | -71.56 | -796.52 | |||
| EPS (Diluted) | -20.30 | -71.60 | -826.00 | |||
| Free Cash Flow | -6.58M | -9.48M | -7.33M | -5.60M | -2.71M | -300.34K |
| Free Cash Flow Per Share | -13.02 | -57.89 | -634.45 | |||
| EBITDA | -9.66M | -11.63M | -7.69M | -5.89M | -2.55M | -1.74M |
| D&A For EBITDA | 1.56M | 290.11K | 5.46K | 6.81K | 5.97K | 6.22K |
| EBIT | -11.22M | -11.92M | -7.70M | -5.89M | -2.55M | -1.74M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 90.24K | 334.00K | 1.92M | 2.58M | 8.42M | 504.75K |
| Short-Term Investments | 2.89M | |||||
| Cash & Short-Term Investments | 90.24K | 334.00K | 1.92M | 5.46M | 8.42M | 504.75K |
| Other Receivables | 14.90K | |||||
| Receivables | 14.90K | |||||
| Prepaid Expenses | 306.12K | 168.91K | 290.77K | 114.47K | 161.15K | 4.87K |
| Total Current Assets | 396.35K | 502.91K | 2.21M | 5.59M | 8.58M | 509.62K |
| Property, Plant & Equipment | 82.63K | 119.70K | 295.37K | 358.73K | 68.71K | 135.55K |
| Other Intangible Assets | 8.65M | 9.84M | ||||
| Long-Term Deferred Charges | 12.12K | |||||
| Other Long-Term Assets | 6.48K | 6.48K | ||||
| Total Assets | 22.81M | 10.48M | 2.51M | 5.95M | 8.65M | 651.64K |
| Accounts Payable | 2.79M | 1.45M | 596.60K | 283.31K | 129.25K | 828.31K |
| Accrued Expenses | 1.78K | 110.45K | 98.14K | 47.50K | ||
| Short-Term Debt | 190.27K | 685.47K | 943.53K | |||
| Current Portion of Long-Term Debt | 684.21K | 596.00K | ||||
| Current Portion of Leases | 82.81K | 77.19K | 60.91K | 52.48K | 62.82K | 66.93K |
| Other Current Liabilities | 611.13K | 6.44M | 331.06K | |||
| Total Current Liabilities | 3.48M | 7.97M | 1.53M | 1.04M | 975.68K | 2.22M |
| Long-Term Debt | 135.09K | |||||
| Long-Term Leases | 112.35K | 154.95K | 238.09K | 304.13K | 62.44K | |
| Other Long-Term Liabilities | 35.75K | 99.69K | 25.28K | 414.51K | ||
| Total Liabilities | 3.63M | 8.22M | 1.80M | 1.90M | 975.68K | 2.28M |
| Common Stock | 9.00 | 20.00 | 2.00 | 20.00 | 136.00 | 93.00 |
| Additional Paid-In Capital | 70.78M | 48.55M | 35.29M | 29.49M | 16.57M | 4.15M |
| Retained Earnings | -51.60M | -46.30M | -34.58M | -25.43M | -8.89M | -5.80M |
| Comprehensive Income & Other | 16.34K | |||||
| Shareholders' Equity | 19.18M | 2.25M | 709.15K | 4.06M | 7.68M | -1.63M |
| Total Liabilities & Equity | 22.81M | 10.48M | 2.51M | 5.95M | 8.65M | 651.64K |
| Total Debt | 195.16K | 232.15K | 1.17M | 1.09M | 748.30K | 1.07M |
| Net Cash (Debt) | -104.92K | 101.86K | 746.67K | 4.38M | 7.67M | -568.15K |
| Net Cash Per Share | -0.21 | 0.62 | 64.65 | |||
| Filing Date Shares Outstanding | 4.76M | 559.13K | 16.31K | |||
| Total Common Shares Outstanding | 1.00M | 202.36K | 16.31K | |||
| Working Capital | -3.08M | -7.46M | 677.15K | 4.55M | 7.60M | -1.71M |
| Book Value Per Share | 19.16 | 11.14 | 43.49 | |||
| Tangible Book Value | 10.53M | -7.59M | 709.15K | 4.06M | 7.68M | -1.63M |
| Tangible Book Value Per Share | 10.52 | -37.49 | 43.49 | |||
| Machinery | 127.47K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -10.26M | -11.72M | -9.14M | -6.59M | -3.03M | -1.15M |
| Depreciation & Amortization | 1.56M | 290.11K | 5.46K | 6.81K | 5.97K | 60.83K |
| Other Amortization | 44.23K | 62.03K | 1.08M | 2.12M | 885.50K | 3.39K |
| Asset Writedown & Restructuring Costs | 109.23K | 109.23K | ||||
| Loss (Gain) From Sale of Investments | -28.55K | -76.54K | ||||
| Stock-Based Compensation | 376.57K | 932.97K | 259.74K | 181.96K | 403.96K | 910.07K |
| Other Operating Activities | 478.43K | 305.07K | 362.56K | -1.44M | -483.09K | -641.65K |
| Change in Accounts Receivable | 211.46K | |||||
| Change in Accounts Payable | 685.44K | 422.99K | 313.30K | 154.06K | -370.38K | 311.35K |
| Change in Other Net Operating Assets | 424.82K | 117.62K | -174.38K | 66.57K | -123.96K | -3.65K |
| Operating Cash Flow | -6.58M | -9.48M | -7.33M | -5.58M | -2.71M | -300.34K |
| Capital Expenditures | -19.05K | |||||
| Cash Acquisitions | -8.44M | -3.04M | ||||
| Sale (Purchase) of Intangibles | -84.00K | -12.00K | ||||
| Investment in Securities | 2.92M | -2.81M | ||||
| Investing Cash Flow | -8.53M | -3.06M | 2.92M | -2.83M | ||
| Short-Term Debt Issued | 250.00K | 50.00K | 687.93K | |||
| Long-Term Debt Issued | 790.00K | 3.94M | 600.72K | |||
| Total Debt Issued | 5.00M | 1.04M | 3.94M | 650.72K | 687.93K | |
| Short-Term Debt Repaid | -190.27K | -59.73K | -685.47K | -50.00K | ||
| Long-Term Debt Repaid | -846.81K | -334.44K | ||||
| Total Debt Repaid | -65.33K | -190.27K | -906.54K | -1.02M | -50.00K | |
| Net Debt Issued (Repaid) | 4.93M | -190.27K | 133.46K | 2.92M | 600.72K | 687.93K |
| Issuance of Common Stock | 5.49M | 11.77M | 3.99M | 10.02M | ||
| Other Financing Activities | -42.69K | -631.81K | -371.68K | -345.00K | ||
| Financing Cash Flow | 10.38M | 10.95M | 3.76M | 2.57M | 10.62M | 687.93K |
| Net Cash Flow | -4.73M | -1.59M | -656.27K | -5.84M | 7.91M | 387.60K |
| Free Cash Flow | -6.58M | -9.48M | -7.33M | -5.60M | -2.71M | -300.34K |
| Free Cash Flow Per Share | -13.02 | -57.89 | -634.45 | |||
| Levered Free Cash Flow | -2.86M | 1.19M | -4.18M | -2.75M | -2.04M | 533.86K |
| Unlevered Free Cash Flow | -2.87M | 1.18M | -4.50M | -3.31M | -2.32M | 562.22K |
| Cash Interest Paid | 89.14K | 125.30K | 86.59K | 164.81K | 39.20K | 293.00 |
| Change in Working Capital | 1.11M | 540.62K | 138.91K | 220.63K | -494.35K | 519.15K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 24.54M | 3.46M | 3.15M | 7.28M | 26.63M | |
| Enterprise Value | 24.64M | 2.04M | 3.56M | 1.44M | 18.27M | |
| Last Close Price | 5.15 | 18.00 | 214.75 | 910.00 | 3,920.00 | |
| PB Ratio | 0.27 | 1.54 | 4.44 | 1.79 | 3.47 | |
| P/TBV Ratio | 2.33 | 4.44 | 1.79 | 3.47 | ||
| Debt / Equity Ratio | 0.01 | 0.10 | 1.66 | 0.27 | 0.10 | -0.66 |
| Net Debt / Equity Ratio | 0.01 | -0.04 | -1.05 | -1.08 | -1.00 | -0.35 |
| Net Debt / EBITDA Ratio | -0.01 | 0.01 | 0.10 | 0.74 | 3.01 | -0.33 |
| Net Debt / FCF Ratio | -0.02 | 0.01 | 0.10 | 0.78 | 2.83 | -1.89 |
| Quick Ratio | 0.03 | 0.04 | 1.25 | 5.26 | 8.63 | 0.23 |
| Current Ratio | 0.11 | 0.06 | 1.44 | 5.37 | 8.79 | 0.23 |
| Return on Equity (ROE) | -90.05% | -791.04% | -383.84% | -112.37% | -100.12% | |
| Return on Assets (ROA) | -49.54% | -114.74% | -113.74% | -50.43% | -34.31% | -182.22% |
| Return on Capital Employed (ROCE) | -58.10% | -474.90% | -791.40% | -120.00% | -33.30% | 111.30% |
| Earnings Yield | -394.13% | -338.50% | -290.49% | -90.57% | -11.37% | |
| FCF Yield | -26.83% | -273.82% | -232.76% | -76.94% | -10.18% | |
| Buyback Yield / Dilution | -1,009.12% | -1,318.24% |